European Heart Journal Advance Access published online on June 26, 2008
European Heart Journal, doi:10.1093/eurheartj/ehn304
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Published on behalf of the European Society of Cardiology. All rights reserved. © The Author 2008. For permissions please email: journals.permissions@oxfordjournals.org
Biodegradable coating for drug-eluting stents—more than a facelift?
Heart Center, Tampere University Hospital, FI-33521 Tampere, Finland
* Corresponding author. Tel: +358 3 247 5111, Fax: +358 3 247 4157, Email: kari.niemela@pshp.fi
This editorial refers to Randomized trial of three rapamycin-eluting stents with different coating strategies for the reduction of coronary restenosis, by J. Mehilli et al. doi:10.1093/eurheartj/ehn253
| The first 10% of the full text of this article appears below. |
Since its introduction 1977, percutaneous coronary angioplasty (PCI) has developed into the most common revascularization method of coronary artery disease (nearly 2 million procedures in Europe in 2003).1,2 Early complications of plain old balloon angioplasty such as acute recoil and abrupt vessel closure were markedly reduced by bare metal stents (BMS; in 1987) providing mechanical scaffolding of the vessel.3 Metallic stents thereby not only reduced the need for emergency coronary artery bypass grafting to <0.5% but nearly halved high restenosis rates observed in up to 30–40% of patients within the first months after balloon angioplasty.4,5 Thereafter, 15 years were needed before the next
![]()
CiteULike
Connotea
Del.icio.us What's this?
Related articles in EHJ:
- Randomized trial of three rapamycin-eluting stents with different coating strategies for the reduction of coronary restenosis
- Julinda Mehilli, Robert A. Byrne, Anna Wieczorek, Raisuke Iijima, Stefanie Schulz, Olga Bruskina, Jürgen Pache, Rainer Wessely, Albert Schömig, Adnan Kastrati, and for the Intracoronary Stenting and Angiographic Restenosis Investigators – Test Efficacy of Rapamycin-eluting Stents with Different Polymer Coating Strategies (ISAR-TEST-3)
EHJ 2008 29: 1975-1982.[Abstract] [FREE Full Text]
This article has been cited by other articles:
![]() |
R. A. Byrne, A. Kastrati, S. Kufner, S. Massberg, K. A. Birkmeier, K.-L. Laugwitz, S. Schulz, J. Pache, M. Fusaro, M. Seyfarth, et al. Randomized, non-inferiority trial of three limus agent-eluting stents with different polymer coatings: the Intracoronary Stenting and Angiographic Results: Test Efficacy of 3 Limus-Eluting Stents (ISAR-TEST-4) Trial Eur. Heart J., October 2, 2009; 30(20): 2441 - 2449. [Abstract] [Full Text] [PDF] |
||||
![]() |
R A Byrne, S Kufner, K Tiroch, S Massberg, K-L Laugwitz, A Birkmeier, S Schulz, J Mehilli, and for the Intracoronary Stenting and Angiographic Re Randomised trial of three rapamycin-eluting stents with different coating strategies for the reduction of coronary restenosis: 2-year follow-up results Heart, September 15, 2009; 95(18): 1489 - 1494. [Abstract] [Full Text] [PDF] |
||||

